TRDA
Price
$7.12
Change
+$0.09 (+1.28%)
Updated
Jun 20 closing price
Capitalization
269.47M
46 days until earnings call
VTGN
Price
$2.06
Change
-$0.00 (-0.00%)
Updated
Jun 20 closing price
Capitalization
59.92M
Interact to see
Advertisement

TRDA vs VTGN

Header iconTRDA vs VTGN Comparison
Open Charts TRDA vs VTGNBanner chart's image
Entrada Therapeutics
Price$7.12
Change+$0.09 (+1.28%)
Volume$221.79K
Capitalization269.47M
VistaGen Therapeutics
Price$2.06
Change-$0.00 (-0.00%)
Volume$396.16K
Capitalization59.92M
TRDA vs VTGN Comparison Chart in %
Loading...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TRDA vs. VTGN commentary
Jun 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRDA is a Hold and VTGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 22, 2025
Stock price -- (TRDA: $7.12 vs. VTGN: $2.06)
Brand notoriety: TRDA and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TRDA: 164% vs. VTGN: 266%
Market capitalization -- TRDA: $269.47M vs. VTGN: $59.92M
TRDA [@Biotechnology] is valued at $269.47M. VTGN’s [@Biotechnology] market capitalization is $59.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $333.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TRDA’s FA Score shows that 0 FA rating(s) are green whileVTGN’s FA Score has 0 green FA rating(s).

  • TRDA’s FA Score: 0 green, 5 red.
  • VTGN’s FA Score: 0 green, 5 red.
According to our system of comparison, TRDA is a better buy in the long-term than VTGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TRDA’s TA Score shows that 4 TA indicator(s) are bullish while VTGN’s TA Score has 3 bullish TA indicator(s).

  • TRDA’s TA Score: 4 bullish, 4 bearish.
  • VTGN’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, TRDA is a better buy in the short-term than VTGN.

Price Growth

TRDA (@Biotechnology) experienced а -6.19% price change this week, while VTGN (@Biotechnology) price change was -7.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.57%. For the same industry, the average monthly price growth was +27.78%, and the average quarterly price growth was +14.34%.

Reported Earning Dates

TRDA is expected to report earnings on Aug 06, 2025.

VTGN is expected to report earnings on Jun 17, 2025.

Industries' Descriptions

@Biotechnology (+9.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRDA($269M) has a higher market cap than VTGN($59.9M). VTGN YTD gains are higher at: -30.339 vs. TRDA (-58.820). TRDA has higher annual earnings (EBITDA): 7.89M vs. VTGN (-52.22M). TRDA has more cash in the bank: 383M vs. VTGN (88.6M). VTGN has less debt than TRDA: VTGN (1.71M) vs TRDA (57M). TRDA has higher revenues than VTGN: TRDA (172M) vs VTGN (698K).
TRDAVTGNTRDA / VTGN
Capitalization269M59.9M449%
EBITDA7.89M-52.22M-15%
Gain YTD-58.820-30.339194%
P/E Ratio12.24N/A-
Revenue172M698K24,642%
Total Cash383M88.6M432%
Total Debt57M1.71M3,327%
FUNDAMENTALS RATINGS
VTGN: Fundamental Ratings
VTGN
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
TRDAVTGN
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 16 days ago
85%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FULC6.990.63
+9.98%
Fulcrum Therapeutics
BRX26.000.21
+0.81%
Brixmor Property Group
AMGN289.35-0.28
-0.10%
Amgen
VYX11.61-0.20
-1.69%
NCR Voyix Corp
PPSI2.63-0.09
-3.49%
Pioneer Power Solutions

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with CRNX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
+1.28%
CRNX - TRDA
57%
Loosely correlated
N/A
ARCT - TRDA
53%
Loosely correlated
-0.49%
BEAM - TRDA
52%
Loosely correlated
-1.35%
VYGR - TRDA
52%
Loosely correlated
-2.30%
ATXS - TRDA
52%
Loosely correlated
-0.51%
More